Prof. Dr. Gerold Schuler

Medizinische Fakultät Lehrstuhl für Haut- und Geschlechtskrankheiten

Predicting the response of uveal melanoma to immunotherapy with MRI assessments (2019) Moreira A, Saake M, Schuler G, Heinzerling L Conference contribution Merkel Cell Carcinoma of the Head and Neck Compared to Other Anatomical Sites in a Real-World Setting: Importance of Surgical Therapy for Facial Tumors (2019) Kirchberger M, Heppt MV, Schuler G, Berking C, Heinzerling L Journal article Automated Good Manufacturing Practice–compliant generation of human monocyte-derived dendritic cells from a complete apheresis product using a hollow-fiber bioreactor system overcomes a major hurdle in the manufacture of dendritic cells for cancer vaccines (2019) Uslu U, Erdmann M, Wiesinger M, Schuler G, Schuler-Thurner B Journal article Enhancing lentiviral transduction to generate melanoma-specific human T cells for cancer immunotherapy (2019) Simon B, Harrer DC, Thirion C, Schuler-Thurner B, Schuler G, Uslu U Journal article Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors (2019) Moreira A, Loquai C, Pfoefer C, Kaehler KC, Knauss S, Heppt MV, Gutzmer R, et al. Journal article The siRNA-mediated downregulation of PD-1 alone or simultaneously with CTLA-4 shows enhanced in vitro CAR-T-cell functionality for further clinical development towards the potential use in immunotherapy of melanoma (2018) Simon B, Harrer DC, Schuler-Thurner B, Schaft N, Schuler G, Dörrie J, Uslu U Journal article BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy (2018) Dörrie J, Babalija L, Hoyer S, Gerer KF, Schuler G, Heinzerling L, Schaft N Journal article Risk Factors for Regional and Systemic Metastases in Patients with Sentinel Lymph Node-negative Melanoma (2018) Erdmann M, Sigler D, Uslu U, Göhl J, Grützmann R, Schuler G, Schellerer V Journal article Eosinophil-cationic protein: A novel liquid prognostic biomarker in melanoma (2018) Moreira A, Krueckel A, Schuler G, Heinzerling L Conference contribution Automated closed-system manufacturing of human monocyte-derived dendritic cells for cancer immunotherapy (2018) Erdmann M, Uslu U, Wiesinger M, Bruening M, Altmann T, Strasser E, Schuler G, Schuler-Thurner B Journal article